Keita Sasa 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（14 件）

• [2025] Potential Involvement of Myostatin in Smooth Muscle Differentiation in Pleomorphic Leiomyosarcoma
  DOI: https://doi.org/10.3390/ijms26167676
• [2024] Clinicopathological characteristics of Japanese patients with breast cancer and <scp><i>MET</i></scp> exon 14 skipping alterations
  DOI: https://doi.org/10.1111/his.15382
• [2024] NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts
  DOI: https://doi.org/10.1038/s41598-024-51211-7
• [2023] Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing
  DOI: https://doi.org/10.1097/corr.0000000000002901
• [2023] Tyrosine kinase alterations in colorectal cancer with emphasis on the distinct clinicopathological characteristics
  DOI: https://doi.org/10.1111/his.15015
• [2022] Endoplasmic Reticulum Stress in Osteosarcoma: IRE1α-XBP1 Inhibition Exerts Anti-Tumor Activity
  DOI: https://doi.org/10.29011/2574-710x.10157
• [2022] Microcystic/reticular schwannoma of the lower leg: Case report with review of literature
  DOI: https://doi.org/10.5348/100063z11ts2022cr
• [2022] Dedifferentiated liposarcoma in the extremity and trunk wall: A multi-institutional study of 132 cases by the Japanese Musculoskeletal Oncology Group (JMOG)
  DOI: https://doi.org/10.1016/j.ejso.2022.08.024
• [2022] Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma
  DOI: https://doi.org/10.1007/s00428-022-03358-9
• [2022] Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
  DOI: https://doi.org/10.1177/15330338221138217

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。